# YH1 in Poorly Controlled Type 2 Diabetes

> **NCT02752880** · PHASE2,PHASE3 · COMPLETED · sponsor: **Chang Gung Memorial Hospital** · enrollment: 46 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** YH1 group
- **DRUG:** placebo group

## Key facts

- **NCT ID:** NCT02752880
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2018-02
- **Final completion:** 2018-02
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2019-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02752880

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02752880, "YH1 in Poorly Controlled Type 2 Diabetes". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT02752880. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*